MYDA Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
MYDA Advisors's XBI Position: Q3 2026 in Review
MYDA Advisors opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q3 2026: 16,000 shares worth $2.52M. The stake represents 0.28% of the portfolio and ranks #74 among its holdings. This is a return to the name: MYDA Advisors previously reported a position in XBI as recently as Q3 2023.
MYDA Advisors first reported a position in XBI in Q4 2017 and has held it in 9 quarters since. The position peaked at $3.81M in Q4 2021. 961 funds tracked by Wall St. Rank hold XBI as of Q3 2026.
- MYDA Advisors held 16,000 shares of State Street SPDR S&P Biotech ETF worth $2.52M as of Q3 2026.
- State Street SPDR S&P Biotech ETF was a new MYDA Advisors position in Q3 2026.
- State Street SPDR S&P Biotech ETF made up 0.28% of MYDA Advisors's portfolio in Q3 2026, its #74 holding.
- MYDA Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q4 2017 and has held it in 9 quarters since.
- MYDA Advisors's State Street SPDR S&P Biotech ETF position peaked at $3.81M in Q4 2021.
- 961 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.
Based on MYDA Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.